Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage Ib Lung Carcinoma”

495 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 495 results

Testing effectiveness (Phase 2)Study completedNCT01610336
What this trial is testing

A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment

Who this might be right for
Non-small Cell Lung Cancer
Novartis Pharmaceuticals 161
Large-scale testing (Phase 3)WithdrawnNCT03048136
What this trial is testing

A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb
Early research (Phase 1)Ended earlyNCT01886573
What this trial is testing

Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 40
Early research (Phase 1)UnknownNCT04432857
What this trial is testing

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

Who this might be right for
Triple-negative Breast CancerNSCLC, Squamous or Non-SquamousUrothelial Carcinoma of the Bladder+2 more
Adlai Nortye Biopharma Co., Ltd. 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07206563
What this trial is testing

Penfluridol for Relapsed/Refractory Small Cell Cancers

Who this might be right for
Small Cell CarcinomaSmall Cell Carcinoma of LungSmall Cell Lung Cancer ( SCLC )+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 33
Early research (Phase 1)Study completedNCT04041011
What this trial is testing

SHR-1316 and Fluzoparib（SHR-3162） in Small Cell Lung Cancer Patients

Who this might be right for
Small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 23
Large-scale testing (Phase 3)Study completedNCT01124253
What this trial is testing

Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Shanghai Jiao Tong University School of Medicine 250
Large-scale testing (Phase 3)Ended earlyNCT00863512
What this trial is testing

Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 34
Testing effectiveness (Phase 2)Ended earlyNCT03995667
What this trial is testing

Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaLimited Stage Lung Small Cell CarcinomaStage I Lung Cancer AJCC v8+14 more
OHSU Knight Cancer Institute 3
Testing effectiveness (Phase 2)UnknownNCT01784107
What this trial is testing

A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Gachon University Gil Medical Center 45
Testing effectiveness (Phase 2)Looking for participantsNCT06512051
What this trial is testing

A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Advanced or Metastatic Non-small Cell Lung Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd. 248
Early research (Phase 1)Study completedNCT05026593
What this trial is testing

IBI110 in Combination With Sintilimab and Chemotherapy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

Who this might be right for
SCLC
Innovent Biologics (Suzhou) Co. Ltd. 60
Early research (Phase 1)Study completedNCT02259114
What this trial is testing

A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)

Who this might be right for
NUT Midline CarcinomaTriple Negative Breast CancerNon-small Cell Lung Cancer With Rearranged ALK Gene/Fusion Protein or KRAS Mutation+3 more
Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 47
Testing effectiveness (Phase 2)Study completedNCT02583477
What this trial is testing

Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
AstraZeneca 23
Not applicableActive Not RecruitingNCT03686007
What this trial is testing

Multimedia Self-Management Intervention for Lung Cancer Surgery Family Caregivers and Patients

Who this might be right for
CaregiverStage I Lung Cancer AJCC v7Stage IA Lung Cancer AJCC v7+7 more
City of Hope Medical Center 380
Testing effectiveness (Phase 2)Looking for participantsNCT06343064
What this trial is testing

Vebreltinib Plus PLB1004 in EGFR-mutated, Advanced NSCLC With MET Amplification or MET Overexpression Following EGFR-TKI

Who this might be right for
Non-Small-Cell Lung Cancer
Avistone Biotechnology Co., Ltd. 156
Early research (Phase 1)Study completedNCT01503177
What this trial is testing

Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Recurrent Malignant MesotheliomaStage IA Malignant MesotheliomaStage IB Malignant Mesothelioma+3 more
Mayo Clinic 15
Testing effectiveness (Phase 2)UnknownNCT04521075
What this trial is testing

A Phase Ib Trial to Evaluate the Safety and Efficacy of FMT and Nivolumab in Subjects With Metastatic or Inoperable Melanoma, MSI-H, dMMR or NSCLC

Who this might be right for
Melanoma Stage IVUnresectable MelanomaNSCLC Stage IV
Ella Therapeutics Ltd 42
Testing effectiveness (Phase 2)Study completedNCT05664971
What this trial is testing

JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer

Who this might be right for
Advanced Lung Cancer
Shanghai Junshi Bioscience Co., Ltd. 119
Testing effectiveness (Phase 2)UnknownNCT05265650
What this trial is testing

Study of BO-112 With Radiotherapy and Nivolumab for Metastatic Refractory NSCLC

Who this might be right for
Non-Small Cell Lung Cancer Metastatic
Clinica Universidad de Navarra, Universidad de Navarra 30
Next Page